Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HRC
276
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $39.5M | 0.09% |
821,500
+314,200
| +62% | +$16M |
|
|
MLNX
277
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $39.4M | 0.09% |
935,583
+118,399
| +14% | +$5.26M |
|
|
WNS
278
DELISTED
WNS Holdings
WNS
| $39.2M | 0.09% |
1,255,803
+17,803
| +1% | +$557K |
|
279
Royal Caribbean
RCL
$86.5B
| $39M | 0.09% |
385,414
+381,799
| +10,562% | +$36.4M |
|
280
Ameriprise Financial
AMP
$48.3B
| $38.9M | 0.08% |
365,100
-119,100
| -25% | -$13.3M |
|
281
Skyworks Solutions
SWKS
$9.73B
| $38.7M | 0.08% |
+503,183
| New | +$40.3M |
|
282
Travel + Leisure Co
TNL
$4.81B
| $38.6M | 0.08% |
1,176,608
+737,659
| +168% | +$25.4M |
|
|
OA
283
DELISTED
Orbital ATK, Inc.
OA
| $38.4M | 0.08% |
430,102
-1,555
| -0.4% | -$131K |
|
284
SLM Corp
SLM
$4.74B
| $38.4M | 0.08% |
5,887,100
+3,779,900
| +179% | +$25.7M |
|
285
Groupon
GRPN
$1.07B
| $38.1M | 0.08% |
620,260
+82,005
| +15% | +$5.27M |
|
286
Emergent Biosolutions
EBS
$377M
| $38.1M | 0.08% |
951,611
+177,400
| +23% | +$6.19M |
|
287
Fidelity National Financial
FNF
$14.6B
| $38.1M | 0.08% |
1,581,005
+529,635
| +50% | +$12.9M |
|
288
Kearny Financial
KRNY
$607M
| $37.9M | 0.08% |
2,994,001
-439,420
| -13% | -$5.35M |
|
289
Eversource Energy
ES
$28.4B
| $37.9M | 0.08% |
742,000
-119,380
| -14% | -$6.07M |
|
|
RPAI
290
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $37.5M | 0.08% |
2,541,055
-111,902
| -4% | -$1.66M |
|
|
WR
291
DELISTED
Westar Energy Inc
WR
| $37.5M | 0.08% |
883,700
+51,300
| +6% | +$2.1M |
|
292
Wabtec
WAB
$51.7B
| $37.4M | 0.08% |
525,300
+436,200
| +490% | +$34.8M |
|
293
Equifax
EFX
$22B
| $37.2M | 0.08% |
334,395
-60,125
| -15% | -$6.5M |
|
|
BNCL
294
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $37.1M | 0.08% |
2,786,870
-51,700
| -2% | -$708K |
|
295
US Physical Therapy
USPH
$1.2B
| $37.1M | 0.08% |
691,200
-59,017
| -8% | -$2.96M |
|
296
Akamai
AKAM
$16.3B
| $37M | 0.08% |
+703,300
| New | +$43.2M |
|
|
PDLI
297
DELISTED
PDL BioPharma, Inc.
PDLI
| $36.6M | 0.08% |
10,345,559
+1,349,405
| +15% | +$5.65M |
|
298
Republic Services
RSG
$66.6B
| $36.5M | 0.08% |
830,861
-138,800
| -14% | -$6.06M |
|
299
Johnson Controls International
JCI
$85.6B
| $36.1M | 0.08% |
+872,679
| New | +$39.5M |
|
|
VVC
300
DELISTED
Vectren Corporation
VVC
| $35.7M | 0.08% |
842,700
-101,700
| -11% | -$4.37M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.